Quest PharmaTech Inc. (QPTFF)

OTCMKTS · Delayed Price · Currency is USD
0.0133
-0.0017 (-11.33%)
At close: Jul 15, 2024
-66.75%
Market Cap 6.10M
Revenue (ttm) n/a
Net Income (ttm) -1.50M
Shares Out n/a
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,000
Average Volume 64,269
Open 0.0133
Previous Close 0.0150
Day's Range 0.0133 - 0.0133
52-Week Range 0.0133 - 0.0400
Beta 0.22
RSI 21.67
Earnings Date May 29, 2025

About Quest PharmaTech

Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. The company’s lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for the potential cancer targets include pancreatic, colon, leukemia, ovarian, and breast cancer. It is also involved in the development of Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. The company is headquartered in Edmonton, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Ragupathy Madiyalakan
Country Canada
Stock Exchange OTCMKTS
Ticker Symbol QPTFF
Full Company Profile

Financial Performance

Financial numbers in CAD Financial Statements

News

There is no news available yet.